Avivagen (Avivagen) EV-to-EBIT : -2.69 (As of May. 06, 2024)

Avivagen EV-to-EBIT Chart

Avivagen Annual Data
	Trend	Oct13	Oct14	Oct15	Oct16	Oct17	Oct18	Oct19	Oct20	Oct21	Oct22
EV-to-EBIT		Get a 7-Day Free Trial					-4.52	-4.91	-6.45	-5.80	-3.77

Avivagen Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
EV-to-EBIT	Get a 7-Day Free Trial															-3.95	-3.77	-3.62	-2.37	-3.02

Competitive Comparison of Avivagen's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Avivagen's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avivagen's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avivagen's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Avivagen's EV-to-EBIT falls into.

Avivagen EV-to-EBIT Calculation

Avivagen's EV-to-EBIT for today is calculated as:

Avivagen's current Enterprise Value is $5.55 Mil.
Avivagen's EBIT for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avivagen  (OTCPK:VIVXF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Avivagen's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jul. 2023 is calculated as:

Avivagen's Enterprise Value for the quarter that ended in Jul. 2023 was $6.33 Mil.
Avivagen's EBIT for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avivagen EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Avivagen's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Avivagen (Avivagen) Business Description